Value for money and the quality and outcomes framework in primary care in the UK NHS

British Journal of General Practice

Volumn 60, Issue 574, 2010, Pages

  Walker, Simon ^a   Mason, Anne R ^a   Claxton, Karl ^b   Cookson, Richard ^a   Fenwick, Elisabeth ^c   Fleetcroft, Robert ^d   Sculpher, Mark ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b Centre for Health Economics   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Cost effectiveness; Family practice; Health care; Physician incentive plans; Quality indicators

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; FINANCIAL MANAGEMENT; GENERAL PRACTICE; HEALTH CARE QUALITY; HUMAN; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; QUALITY ADJUSTED LIFE YEAR; QUALITY AND OUTCOMES FRAMEWORK; REIMBURSEMENT; UNITED KINGDOM;

COST-BENEFIT ANALYSIS; ENGLAND; FAMILY PRACTICE; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIAN INCENTIVE PLANS; QUALITY INDICATORS, HEALTH CARE; QUALITY OF HEALTH CARE; QUALITY-ADJUSTED LIFE YEARS; STATE MEDICINE;

EID: 77952812628     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp10X501859     Document Type: Article

References (29)

1. Doran T, Fullwood C. Pay for performance: Is it the best way to improve control of hypertension? Curr Hypertens Reps 2007; 9(5): 360-367.
2. Institute of Medicine. Rewarding provider performance: aligning incentives in medicare.Washington, DC: Institute of Medicine, 2006.
3. Doran T, Fullwood C, Reeves D, et al. Exclusion of patients from pay-for-performance targets by English physicians. N Engl J Med 2008; 359(3): 274-284. (Pubitemid 352008442)
4. Petersen LA,Woodard LD, Urech T, et al. Does pay-for-performance improve the quality of health care? Ann Intern Med 2006; 145(4): 265-272.
5. The National Health Service (General Medical Services Contracts) Regulations 2004. London: The Stationery Office Limited, 2004.
6. Secretary of State for Health. Primary health care: expenditure. House of Commons HansardWritten Answers for 26 March 2009; Column 684W. http://www.publications.parliament.uk/pa/cm200809/cmhansrd/cm090326/text/ 90326w0026.htm (accessed 9 May 2010)
7. Department of Health. Investing in general practice: the new general medical services contract. London: Department of Health, 2003.
8. Campbell S, Reeves D, Kontopantelis E, et al. Quality of primary care in England with the introduction of pay for performance. N Engl J Med 2007; 357(2): 181-190. (Pubitemid 47057740)
9. Doran T, Fullwood C, Kontopantelis E, Reeves D. Effect of financial incentives on inequalities in the delivery of primary clinical care in England: analysis of clinical activity indicators for the quality and outcomes framework. Lancet 2008; 372(9640): 728-736.
10. Kmietowicz Z. New GP contract: modernisation or miscalculation? BMJ 2006; 333(7580): 1192.
11. Fenwick E, Claxton K, Sculpher M. The value of implementation and the value of information: combined and uneven development. Med Decis Making 2008; 28(1): 21-32.
12. National Institute for Health and Clinical Excellence (NICE). Guide to the methods of technology appraisal. London: National Institute for Health and Clinical Excellence, 2008.
13. Organisation for Economic Co-operation and Development. Prices and Purchasing Power Parities (PPP). http://www.oecd.org/department/0,3355,en-2649- 34347-1-1-1-1-1,00.html: (accessed 9 May 2010).
14. Curtis L, Netten A. Unit costs of health and social care. Canterbury: Personal Social Services Research Unit, University of Kent, 2006.
15. National Institute for Health and Clinical Excellence. CG034: Management of hypertension in adults in primary care (partial update of NICE clinical guideline 18). London: National Institute for Health and Clinical Excellence, 2006; 45.
16. Jones L, Griffin S, Palmer S, et al. Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation. Health Technol Assess 2004; 8(38): iii-iv, 1-196. (Pubitemid 39591603)
17. National Institute for Clinical Excellence. Prophylaxis for patients who have experienced a myocardial infarction: drug treatment, cardiac rehabilitation and dietary manipulation - guideline. London: National Institute for Clinical Excellence, 2001.
18. Briggs A,Mihaylova B, Sculpher M, et al. The cost-effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA Study. Heart 2006; 93(9): 1081-1086. (Pubitemid 47310987)
19. Karnon J, Peters J, Platt J, et al. Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis. Health Technol Assess 2004; 8(20): iii, 1-78. (Pubitemid 38812219)
20. Palmer A, Annemans L, Roze S, et al. Cost-effectiveness of irbesartan in type II diabetic nephropathy with hypertension. A Spanish perspective. Nefrologia 2004; 24(3): 231-238. (Pubitemid 39369194)
21. Facey K, Cummins E,Macpherson K, et al. Organisation of services for diabetic retinopathy screening. Glasgow: Health Technology Board for Scotland (HTBS), 2002.
22. Boyko WL, Glick HA, Schulman KA. ACE inhibitors in the management of congestive heart failure: comparative economic data. Am Heart J 1999; 137(5): S115-S119. (Pubitemid 29226329)
23. Walker S, Palmer S, Sculpher M. The role of NICE technology appraisal in NHS rationing. Br Med Bull 2007; 81-82: 51-64. (Pubitemid 351194479)
24. Hippisley-Cox J, Vinogradova Y, Coupland C. Time series analysis for 2001-2006 for selected clinical indicators from the Quality and Outcomes Framework. NHS. The Information Centre for Health and Social Care, 2007.
25. Petersen R, Garrett JM,Melvin CL, Hartmann KE.Medicaid reimbursement for prenatal smoking intervention influences quitting and cessation. Tob Control 2006; 15(1): 30-34. (Pubitemid 43190319)
26. Sigfrid LA, Turner C, Crook D, Ray S. Using the UK primary care Quality and Outcomes Framework to audit health care equity: preliminary data on diabetes management. J Public Health 2006; 28(3): 221-225. (Pubitemid 44408924)
27. Doran T, Fullwood C, Gravelle H, et al. Pay-for-performance programs in family practices in the United Kingdom. N Engl J Med 2006; 355(4): 375-384. (Pubitemid 44127540)
28. Jewell D. Careful with the unintended consequences. Br J Gen Pract 2005; 55(514): 397.
29. Department of Health. Developing the Quality and Outcomes Framework: proposals for a new, independent process. Leeds: Department of Health, 2008.